Right Ventricle to Pulmonary Artery Conduits in Adult Patients with Conotruncal Lesions: Single-Center Experience
The Thoracic and Cardiovascular Surgeon · 2026-01 · 74 (S 02) · S71-S98
DOI: 10.1055/s-0046-1817362 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Thoracic and Cardiovascular Surgeon, online erschienen am 17.02.2026. Verfasst von E. Urganci und 5 weiteren Autor:innen.
Abstract (Originalsprache)
All articles of this category (opens in new window)
Background
The number of adult patients with congenital conotruncal anomalies requiring the replacement of a previously implanted right ventricle to pulmonary artery conduit is rising. Novel types of substitutes with less structural deterioration and a low number of re-interventions are needed. This retrospective analysis compares Xenografts, cryopreserved homografts, and decellularized homografts in adult patients with conotruncal anomalies.
Methods
All Patients above the age of 18 years with conotruncal anomalies who had undergone a right ventricle to pulmonary artery conduit placement or implantation using a Xenograft (Edwards-Inspiris, Abbott-Trifecta, Medtronic-Mosaic), cryopreserved homograft, or decellularized homograft between 2015 and 2025 were included in this single-center retrospective analysis. Demographic data, medical history, and operative data of each patient were obtained. The latest transthoracic echocardiography findings in routine follow-up and clinical reports were collected. Statistics: Kruskal–Wallis test for the comparison of medians and chi-square test for comparison of categorical data were used. Kaplan–Meier estimated survival curves with 95% confidence interval were calculated, log-rank test was performed to compare survival between groups. Kaplan–Meier curves were used to analyze freedom from reoperation in each group and of the total cohort.
Results
A total of 53 patients were included: 13 received decellularized homografts, 14 cryopreserved homografts, and 26 xenografts. Median age at surgery was 29 years (IQR: 21–38). The most frequent primary diagnosis was tetralogy of Fallot (39.6%), followed by congenital pulmonary stenosis (13.2%) and dTGA with LVOTO (11.3%). Median follow-up was 59 months. Hemodynamic results were similar, with a median mean gradient of 7 mm Hg and peak gradient of 12 mm Hg, with no intergroup differences ( p = 0.923 and p = 0.907, respectively). Prosthesis regurgitation was trivial in 11 patients and mild in 4, with no severe regurgitation reported ( p = 0.347). Two patients in the bioprosthetic group and one patient in the cryopreserved homograft group required reoperation at 19, 81, and 97 months after the date of implantation.
Conclusion
At a median follow-up period of 5 years, decellularized homografts in adult patients with conotruncal anomalies demonstrate no surgical reinterventions compared with cryopreserved homografts and xenografts. Publication History Article published online: 17 February 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
Zitieren
APA
Urganci, E., Alexandra, A., Atteneder, C., Werner, P., Murin, P., & Zimpfer, D. (2026). Right Ventricle to Pulmonary Artery Conduits in Adult Patients with Conotruncal Lesions: Single-Center Experience. The Thoracic and Cardiovascular Surgeon, 74(S 02), S71-S98. https://doi.org/10.1055/s-0046-1817362
Vancouver
Urganci E, Alexandra A, Atteneder C, Werner P, Murin P, Zimpfer D. Right Ventricle to Pulmonary Artery Conduits in Adult Patients with Conotruncal Lesions: Single-Center Experience. The Thoracic and Cardiovascular Surgeon. 2026;74(S 02):S71-S98. doi:10.1055/s-0046-1817362
BibTeX
@article{Urganci2026,
author = {Urganci, E. and Alexandra, A. and Atteneder, C. and Werner, P. and Murin, P. and Zimpfer, D.},
title = {Right Ventricle to Pulmonary Artery Conduits in Adult Patients with Conotruncal Lesions: Single-Center Experience},
journal = {The Thoracic and Cardiovascular Surgeon},
year = {2026},
volume = {74},
number = {S 02},
pages = {S71--S98},
doi = {10.1055/s-0046-1817362}
}
EUVIMED